INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving SelectQuote, Inc. following a DOJ lawsuit alleging illegal kickbacks related to Medicare Advantage plans [1][3]. Group 1: Investigation and Legal Actions - Pomerantz LLP is representing investors of SelectQuote and is looking into claims of securities fraud or other unlawful practices by the company and its officers [1]. - The U.S. Department of Justice filed a False Claims Act complaint against SelectQuote and other insurers, alleging that from 2016 to 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [3]. - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.24%, closing at $2.56 per share on May 1, 2025 [3]. Group 2: Company Background - SelectQuote, Inc. operates in the health insurance sector and is involved in the marketing of Medicare Advantage plans [3]. - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud and corporate misconduct [4].